New research agreement between US and UK
The UK and US have reached a deal to develop a special relationship for science.
An agreement between the two countries aims to make it easier for researchers to travel, collaborate and share facilities.
US science bodies are said to be "eager" to take advantage of research opportunities lost because of Brexit.
The deal is part of government efforts to develop research collaborations outside the EU.
The agreement, signed by the Science Minister Jo Johnson and his US counterparts, states that national laws will "seek to facilitate" freer movement of people and scientific equipment.
Speaking in Washington, Mr Johnson said that the deal would help to ensure that the UK would maintain its global lead in many areas of research.
"Our continued collaboration with the US on science and innovation is beneficial to both of our nations, and through this agreement we are sharing expertise to enhance our understanding of many important topics that have the potential to be world changing,"
Ryanair, the newest airline **** up
A reported pilot shortage has been blamed for the airline canceling more than 2,000 trips across Europe between September 16 and the end of October.
According to insiders at the airline, staff members were asked not to take their time off during the peak travel season, mainly around the school holidays.
Ryanair passengers have described their “miserable” experiences at the hands of the budget airline after a pilot shortage forced the company to cancel flights, leaving passengers “stranded.”
Hundreds of holidaymakers have been forced to pay for hotels, flight changes and living costs after being left without a journey home – as well as shelling out £25 (US$34) per call to the helpline.
However, apparent mismanagement of the booking system resulted in pilots taking the same leave, leaving planes unmanned.
However, one pilot said this excuse only scratches the surface.
Former Ryanair Captain James Atkinson said “There’s an underlying problem at Ryanair, which is quite simply that the company cannot replace pilots as fast as they quit, meanwhile, the fatigue of flying for Ryanair is quite real. When I was there, I was regularly sent out of my base to fly on my days off, and without pay – to distant Ryanair bases that had a staffing shortage.
“I would take connecting flights and sometimes overnight layovers to arrive (hotel paid by me, and not reimbursed), once there, I would report for duty, fly a heavy flight schedule for five consecutive days, then face the arduous journey back to my home base. It was a soul-destroying experience.”
Customers have been told they will be reimbursed – only after they have filled out the complaints procedure and compensation forms, meaning passengers could be left waiting days, or even weeks, for a refund.
Sterilisation implant halted from use, too damn ******
Sales of a sterilisation device are being halted in all countries bar the US, weeks after the Victoria Derbyshire show reported it could cause problems.
The Essure implant, which is available on the NHS, has left some women in chronic pain, and some have even needed hysterectomies to remove it.
The pharmaceutical company Bayer said the decision to stop sales was being taken for commercial reasons.
The sale of the implants in the EU was temporarily suspended last month.
Bayer has asked hospitals in the UK not to use their existing stocks during this time.
It is a voluntary request and up to individual trusts to decide what to do.
The small coil implants, which are made of nickel and polyester (PET) fibres, are used as a sterilisation device to stop eggs reaching the womb.
They are inserted into the fallopian tubes where they are designed to trigger inflammation, causing scar tissue to build up and eventually block the tubes, known as a hysteroscopic sterilisation.
They can cause intense pain, and some women are thought to react badly to the nickel and plastic.
Because of the way the coils attach to the fallopian tubes, the only way to take them out is to remove a woman's fallopian tubes and often her uterus.
In other cases the device has been found to perforate a fallopian tube and fallen out, embedding itself elsewhere in the body.
A statement from Bayer said: "We would like to reassure all patients, especially those with Essure, as well as health professionals, that this decision has been taken for commercial reasons and is not linked to any problems with safety or with the quality of the product.
"According to our scientific assessment, the positive risk-benefit ratio of Essure remains unchanged, the safety and effectiveness of Essure is supported by over 10 years of scientific research and real-life clinical experience."
The US is the biggest market for the product. More than 15,000 women have reported problems to the US Food and Drug Administration, which include "pain", "allergic reactions" and the coil moving to other parts of the body.
Last year, the FDA ordered Bayer to carry out long-term testing on Essure and put a warning on its packaging.